| Clinical data | |
|---|---|
| Trade names | Lufyllin |
| Other names | 7-(2,3-Dihydroxy-propyl)theophylline |
| AHFS/Drugs.com | Consumer Drug Information |
| MedlinePlus | a682494 |
| Routes of administration | By mouth |
| ATC code | |
| Legal status | |
| Legal status | |
| Identifiers | |
| |
| CAS Number |
|
| PubChemCID | |
| IUPHAR/BPS | |
| DrugBank |
|
| ChemSpider |
|
| UNII | |
| KEGG |
|
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard(EPA) | |
| ECHA InfoCard | 100.006.843 |
| Chemical and physical data | |
| Formula | C10H14N4O4 |
| Molar mass | 254.246 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
Diprophylline (INN)[1] ordyphylline (USAN) (trade namesDilor,Lufyllin) is axanthinederivative withbronchodilator andvasodilator effects. It is used in the treatment ofrespiratory disorders likeasthma,cardiac dyspnea, andbronchitis. It acts as anadenosine receptorantagonist andphosphodiesterase inhibitor.[2][3]
Thisdrug article relating to therespiratory system is astub. You can help Wikipedia byexpanding it. |